Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

sanofi-aventis
1 Onslow Street, Guildford, Surrey, GU1 4YS, UK
Telephone: +44 (0)1483 505 515
Fax: +44 (0)1483 535 432
Medical Information e-mail: uk-medicalinformation@sanofi-aventis.com

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 04/05/2011
PIL Apidra 100U/ml solution for injection in cartridge

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 04/05/2011 and displayed until Current
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 23/12/2009 and displayed until 04/05/2011
Reasons for adding or updating:
  • Change due to harmonisation of PIL.
Updated on 05/01/2009 and displayed until 23/12/2009
Reasons for adding or updating:
  • Changes to therapeutic indications
Updated on 29/04/2008 and displayed until 05/01/2009
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 18/06/2007 and displayed until 29/04/2008
Reasons for adding or updating:
  • Change to date of revision
Updated on 11/07/2006 and displayed until 18/06/2007
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC

Active Ingredients/Generics

 
  insulin glulisine